Share Name Share Symbol Market Type Share ISIN Share Description
Biofocus Plc LSE:BIO London Ordinary Share GB0008381823 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 29.75p 0.00p 0.00p - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology - - - - 15.00

Biofocus (BIO) Latest News

Real-Time news about Bionostics (London Stock Exchange): 0 recent articles
More Biofocus News
Biofocus Takeover Rumours

Biofocus (BIO) Share Charts

1 Year Biofocus Chart

1 Year Biofocus Chart

1 Month Biofocus Chart

1 Month Biofocus Chart

Intraday Biofocus Chart

Intraday Biofocus Chart

Biofocus (BIO) Discussions and Chat

Biofocus Forums and Chat

Date Time Title Posts
15/1/201604:19US BIOTECH2
06/8/201318:32Microcap Biotech Thread (SAR,PYC,VAL,RENE,MEDU,SUMM)9
06/8/201318:30Biotech Bull thread- charts please27
22/2/200814:16Bionostics( formely ferraris)320

Add a New Thread

Biofocus (BIO) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Biofocus trades in real-time

Biofocus (BIO) Top Chat Posts

Biofocus Daily Update: Biofocus Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker BIO. The last closing price for Biofocus was 29.75p.
Biofocus Plc has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 50,411,194 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Biofocus Plc is £14,997,330.22.
cyberpost: that email KIU got... interesting to note this : ".... temporary collapse of the share price" the CEO believes it will be temporary...
keepitup: From the Group Chief Executive. Yes 20mins ago. Sounds very positive, i will print the full email: Thank you for your note. I am fully aware that you and many investors like you have had a very difficult time over the past couple of years. When I joined Ferraris Group last October, it was with the understanding that the Board of Directors would allow me to do the things necessary to revive a stagnant organization and begin to pay down the overwhelming debt. In the past thirteen months the Board has done everything possible to support my efforts with the result being a revitalization of the businesses, record trading and profits in both the third and fourth quarters of fiscal year 2007 and significant progress in paying down our debt. As you can imagine, such rapid improvement in a company's performance is recognized by knowledgeable investors as an indication that the company's true value exceeds its market capitalization. As you know, some time ago we announced to the market that Bionostics plc was in discussions with a potential acquirer. The rules of the Takeover Panel of the London Stock Exchange are such that I am unable to give you any further information until those discussions proceed to a more definitive stage, whether it be positive or negative. I believe, however, that because we were forced to make that announcement, investors who expected to hear about the outcome sooner have become unnecessarily concerned and have caused an artificial and temporary collapse of the share price. I take my responsibilities to shareholders very seriously; I believe that it is my responsibility to do what is best for our shareholders, whether it is best or preferable for me or any member of the Board or executive management. I assure you that an announcement will be made at the earliest possible moment, but until that is possible I hope that you will understand my inability to comment. Our preliminary results for fiscal year 2007 will be announced very shortly. I am confident you will then have your questions answered. If, knowing my limitations, you would like to discuss this further, please feel free to call me. I apologize for your frustration, but I believe that we will have more information in the near future. Michael H. Thomas Group Chief Executive Officer Bionostics plc
aquilla: Just a little example of what I mean: I went back to one thread of a company (LNX) I followed for a while. This was the post: Red Dog - 25 May'07 - 13:46 - 500 of 543 "Some investment friends of mine were in Spain resently and they are of the mind that Lennox is in more trouble than published so far. They are asking. Will Lennox go under in the next 6 months?. Will the Company come cap in hand to their investors for more money to bail out the Company at 0.75p or less?. Will they make a profit in the next 3 years?, they don't think so. Should investors bite on the bullet and sell to invest elsewere?. It sounds like the time has come to take action to save what is left of ones investment." Three weeks later and he was ramping the company for all he was worth: Red Dog - 15 Jun'07 - 10:34 - 144 of 1247 Morning all. I was out all day, so I am only now catching up with today's trades. Looks positive. Not much I can add to this BB at this time. The results will consolidate the share price at 6p plus, if they state the Company is on track to return to profits and they have started to reduce their debt. At 4.5p the shares are very cheap and those not in will regret that they stood on the side lines and let this share get away. STRONG BUY I WOULD SAY. Having deramped the company so he could buy shares on the cheap, he then ramped the company for all he could so he could offload!!
aquilla: Cyberpost, by "boosted" the share price, I don't mean deliberately so, but the fact that they are buying would, in the normal course of events, especially in such a thinly traded share, have lifted the share price Instead the opposite has happened. By "insiders" I am referring to anyone with this supposed insider information. It seems highly unlikely, though I could be quite wrong, that only one person would have gotten to know this info. He claims to have bought 400,000 shares on the back of it, so just imagine if a few others were buying as well. But there has been no evidence of large scale buying and in fact as we have seen the share price has gone down! And do you really think an "insider" would come and publicize the fact on these boards??
cyberpost: Aquilla some years back Misys made an approach for another listed outfit called DBS Management. DBS announced that an approach had been made and any offer would be significantly above the then current share price (around 55p). The share raced to 90p. But over the weeks it dropped to around 65p. I got info (from a mate who worked at DBS) that an offer would be made at 150p. So I bought £30k's worth. It took another 4 weeks before that news was officially announced. In that time the share dropped as loow as 55p. It then rose to around 65p. And wham the RNS came and the share doubled on the day. SO in effect the market hadnt got any whiff of the news i had got (and I am sure many others got). I am sure there are many other examples, but the above is a personal one that I benefitted from. And remember that was FTSE 250 company, so any rumours would be more widespread. This is a very tiny company which the market can completely forget as I dont think its on any fund managers radar. Like so many, its a forgotten mini cap.
gjcorr: BlackPerl Something doesn't make sense to me. This share has been drifting down for a while. If you really KNEW or were even confident of a buyout at 30p, you would let it drift down and top up. I can't believe you are so altruistic that you spread your news, knowing it may keep the share price up and deny you a chance yo buy at lower prices. Some possibilities come to mind.. 1)You are ramping, and shorting this on price increases because you know the buyout is not going ahead and ultimately expect a share price crash. 2) You know there is a buyout but share price drops, will lower the offer price, hence you are trying to talk up the price 3) You don't know anything about the buyout, but you are seroiusly long in this stock and depressed at seeing your holding shrink in value, so you ramp
keepitup: the results will be out at the same time as the buy-out details im guessing? is there a deadline for there final results? someone mentioned two weeks. BlackPerl - good to have you here mate, how many have you got now, you going to continue topping up this week? william - your nickname should be quick-eye ;) aquilla - yes the trading was odd on friday; the plus markets gave very good prices for those sells if the share price was reflective. who knows, if i had to guess they were sells and the mm's have another buyer in the background and not a seller - price often drops when a large player comes aboard, if im right we should see a good increase after they have filled his order- or not as im only guestimating. good luck here for the coming week.
tunturiflyer: Distinct lack of RNS commenting on "recent moves in the share price". Over the past few months, BIO has released an RNS every time there has been a move. Not sure how to interpret a lack of RNS. Usually a move down from 22pence has preceded a sharp upward move. Optimistically, I wonder if NAV is close to making an offer. On the other hand, NAV could have looked at the books, and is walking away in horror.
aquilla: Well, it looks like the news is out! In today's Sunday Times: "The activist fund management group North Atlantic Value is poised to launch a takeover bid for Bionostics valuing the medical diagnostics firm at about £15m. According to bankers, North Atlantic, which is backed by a group of investors, is planning to bid 30p a share for Bionostics. The offer is a 30% premium to the share price of 23p on Friday. North Atlantic is already Bionostic's largest shareholder with a 26.76% stake held in four of the funds it manages. Bionostics shares have slumped by 85% since hitting 170p in 2004. The group sold off its cardiac monitoring assets in June 2006 to Spacelabs Healthcare for £14m. However, in April Bionostics announced it had swung to a £490,000 loss for the first six months of the year against a profit of £536,000 a year earlier." I spoke to the company earlier in the week and got a pretty strong hint that news (one way or the other) would be coming soon. The figure also coincides with the maximum price that N.Atlantic previously paid for the shares and what I thought the offer price would be. Interesting that there was a sharp drop in share price just before the conclusion of talks (if this turns out to be the case). I mentioned in a previous post the case of RTD where exactly the same thing happened: a sharp drop, designed to trigger stop losses and make shareholders think bad news was on the way, only to be followed by the announcement of successful conclusion of talks! Ps I think the share price will rocket tomorrow.
aquilla: Some interesting points 2lance which raise some questions. When you talk about senior management are you talking about the new ceo, Michael Thomas, whom I thought had a good record? Secondly, if the assets are not worth the present share price why has Atlantic Value taken around a 20% stake in the company at prices which cannot be much lower, if at all, than the present sp? Thirdly, the loss making divisions have been taken out, leaving the traditionally profitable ones. Finally, why has the company received an approach (unless the offerors plan to offer a lower price than the present share price for the company, which can happen) if the company is overvalued?
Biofocus share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161026 09:28:12